Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 224: 109352, 2023 02 15.
Article in English | MEDLINE | ID: mdl-36455646

ABSTRACT

The recent increase in clinical research on the potential therapeutic uses of classic psychedelics has prompted the need to revisit the assessment of the abuse potential of these drugs. The term "classic psychedelic" is used in this manuscript to describe serotonergic 5-HT2A agonists that alter perception, cognition, and mood (i.e., psychedelic effects) and that are currently controlled in Schedule I of the Controlled Substances Act (CSA). Schedule I drugs are subject to the most restrictive controls under the CSA, as they are considered to have a high abuse potential and no currently accepted medical use in the United States (USA). However, these classic psychedelics were placed in Schedule I at the time the CSA was enacted in 1970, and their abuse potential has not been systematically assessed using modern methodology. This paper provides an overview of scientific evaluation of the abuse potential of classic psychedelics and delineates the data that will be needed in support of a recommendation for the rescheduling, if a drug product containing a classic psychedelic gains FDA approval. This article is part of the Special Issue on 'National Institutes of Health Psilocybin Research Speaker Series'.


Subject(s)
Hallucinogens , United States , Hallucinogens/adverse effects , Psilocybin/adverse effects , Drug Development
2.
Psychopharmacology (Berl) ; 236(3): 845-860, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30969348

ABSTRACT

BACKGROUND AND RATIONALE: Cathinones are amphetamine analogues that produce stimulant effects with rewarding properties. For many decades, synthetic cathinones have been used in the United States (USA) for abuse purposes, leading to concern about public safety by the federal government. Under the Controlled Substances Act (CSA), the federal government may place drugs with high abuse potential but no currently accepted medical use into Schedule I of the CSA. The process of scheduling an abusable drug involves both the Department of Health and Human Services (HHS), through the Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA), and the Department of Justice, through the Drug Enforcement Administration (DEA). RESULTS: This paper details how numerous synthetic cathinones were placed under CSA control between 1973 and 2018, with an emphasis on 10 cathinones that were placed into Schedule I in 2017 (butylone, naphyrone, pentylone, pentedrone, 3-fluoro-N-methylcathinone (FMC), 4-FMC, 4-methyl-N-ethylcathinone, 4-methyl-pyrrolidinopropiophenone, alpha-pyrrolidinobutiophenone, and α-pyrrolidinopentiophenone). A summary is provided of the scientific and medical analysis performed by HHS, in the form of an Eight-Factor Analysis (8FA), as prescribed by the CSA. This 8FA was then evaluated and signed by the Assistant Secretary for Health at HHS and transmitted to DEA, which permanently placed the 10 cathinones into Schedule I after public notices were published into the Federal Register. DISCUSSION AND CONCLUSIONS: Understanding the scientific data, analysis, and complex process utilized by the US federal government in the CSA scheduling of cathinones with abuse potential and no accepted medical use is important for transparency in governmental decision-making.


Subject(s)
Alkaloids/standards , Controlled Substances/standards , Synthetic Drugs/standards , United States Food and Drug Administration/legislation & jurisprudence , Alkaloids/adverse effects , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/standards , Controlled Substances/adverse effects , Humans , Pentanones , Prescription Drug Diversion/legislation & jurisprudence , Prescription Drug Diversion/prevention & control , Pyrrolidines , Synthetic Drugs/adverse effects , United States
3.
J Biol Chem ; 280(48): 39684-92, 2005 Dec 02.
Article in English | MEDLINE | ID: mdl-16188888

ABSTRACT

When human DNA polymerase eta (pol eta) encounters N6-deoxyadenosine adducts formed by trans epoxide ring opening of the 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BaP DE) isomer with (+)-7R,8S,9S,10R configuration ((+)-BaP DE-2), misincorporation of A or G and incorporation of the correct T are equally likely to occur. On the other hand, the enzyme exhibits a 3-fold preference for correct T incorporation opposite adducts formed by trans ring opening of the (-)-(7S,8R,9R,10S)-DE-2 enantiomer. Adducts at dA formed by cis ring opening of these two BaP DE-2 isomers exhibit a 2-3-fold preference for A over T incorporation, with G intermediate between the two. Extension one nucleotide beyond these adducts is generally weaker than incorporation across from them, but among mismatches the (adducted A*) x A mispair is the most favored for extension. Because mutations can only occur if mispairs are extended, this observation is consistent with the occurrence of A x T to T x A transversions as common mutations in animal cells treated with BaP DE-2 isomers. Adducts with S absolute configuration at the point of attachment of the hydrocarbon to the base inhibit incorporation and extension by pol eta to a lesser extent than their R counterparts. Template-primers containing each of the four isomeric dA adducts derived from BaP DE-2 and two adducts derived from 9,10-epoxy-7,8,9,10-tetrahydrobenzo-[a]pyrene in which the 7- and 8-hydroxyl groups of the DEs are replaced with hydrogens exhibit reduced electrophoretic mobilities relative to the unadducted oligonucleotides. This effect is largely independent of DNA sequence. Decreased mobility correlates with an increased rate of incorporation by pol eta, suggesting a systematic relationship between the overall DNA structure and efficiency of the enzyme.


Subject(s)
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide/chemistry , Base Pair Mismatch , DNA Adducts , DNA Repair , DNA-Directed DNA Polymerase/physiology , DNA/chemistry , Deoxyadenosines/chemistry , DNA Primers/chemistry , DNA-Directed DNA Polymerase/chemistry , Electrophoresis, Polyacrylamide Gel , Humans , Hydrocarbons/chemistry , Hydrogen/chemistry , Kinetics , Models, Chemical , Mutation , Nucleic Acid Conformation , Oligonucleotides/chemistry , Sequence Analysis, DNA
4.
Photochem Photobiol Sci ; 2(11): 1205-8, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14690235

ABSTRACT

Laser flash photolysis is used to examine reaction rates of four arylnitrenium ions: N-methyl-N-(4-chlorophenyl)-, -(4-biphenylyl)-, -(4-methylphenyl)-, and -(4-methoxyphenyl)nitrenium ion. These intermediates are generated from photolysis of appropriately substituted N-aminopyridinium ions. Kinetic analysis of trapping rates shows that the nitrenium ions react with weak nucleophiles in the order 4-Cl approximately 4-Me > 4-Ph > 4-OMe. Generally, amines react with the arylnitrenium ions at or near the diffusion-limited rate. Only in cases where the least reactive nitrenium ion (4-OMe) reacts with sterically hindered amines is any deviation from this generalization observed. The addition of a 2-acetyl substituent to these structures produces an interesting effect. In the case of the 4-Cl and 4-Ph analogs, the electron-withdrawing acetyl group decreases the rate of nucleophilic addition, yet with the 4-OMe and 4-Me compounds, the acetyl group increases the rate of addition. These results are discussed in terms of competing electronic and steric effects.

5.
J Am Chem Soc ; 124(14): 3567-77, 2002 Apr 10.
Article in English | MEDLINE | ID: mdl-11929245

ABSTRACT

An arylnitrenium ion, N-methyl-N-(4-biphenylyl)nitrenium ion, was generated through photolysis of 1-(N-methyl-N-4-biphenylyl)amino-2,4,6-trimethylpyridinium tetrafluoroborate, and its reactions with various donor-substituted arenes (e.g., 1,3,5-trimethoxybenzene, mesitylene, 1,4-dimethoxybenzene, hexamethylbenzene, etc.) were examined using product analysis and laser flash photolysis. In general, trapping of the short-lived nitrenium ion by the arenes leads to three types of products: (1) the parent amine, N-methyl-N-4-biphenylylamine; (2) an ortho-adduct, where the ring position ortho to the nitrenium ion center is bonded to the arene ring; and (3) an N-adduct, where the nitrenium ion nitrogen is bonded to the trap. Laser flash photolysis studies show that the rates of these trapping reactions vary from 10(4) to 10(9) M(-1) s(-1), depending on the structure of the arene trap. These trapping rate constants do not correlate with the one-electron oxidation potential of the arene, nor with the expected stability of a sigma-complex derived from direct electrophilic aromatic substitution. It is argued that the observed rate constants correspond to initial formation of a pi-complex between the arylnitrenium ion and the arene trap. This complex then forms the observed products.

6.
J Biol Chem ; 277(14): 11765-71, 2002 Apr 05.
Article in English | MEDLINE | ID: mdl-11821420

ABSTRACT

Human DNA polymerase eta was used to copy four stereoisomeric deoxyguanosine (dG) adducts derived from benzo[a]pyrene 7,8-diol 9,10-epoxide (diastereomer with the 7-hydroxyl group and epoxide oxygen trans (BaP DE-2)). The adducts, formed by either cis or trans epoxide ring opening of each enantiomer of BaP DE-2 by N(2) of dG, were placed at the fourth nucleotide from the 5'-end in two 16-mer sequence contexts, 5' approximately CG*A approximately and 5' approximately GG*T. poleta was remarkably error prone at all four diol epoxide adducts, preferring to misincorporate G and A at frequencies 3- to more than 50-fold greater than the frequencies for T or the correct C, although the highest rates were 60-fold below the rate of incorporation of C opposite a non-adducted G. Anti to syn rotation of the adducted base, consistent with previous NMR data for a BaP DE-2 dG adduct placed just beyond a primer terminus, provides a rationale for preferring purine misincorporation. Extension of purine misincorporations occurred preferentially, but extension beyond the adduct site was weak with V(max)/K(m) values generally 10-fold less than for misincorporation. Mostly A was incorporated opposite (+)-BaP DE-2 dG adducts, which correlates with published observations that G --> T is the most common type of mutation that (+)-BaP DE-2 induces in mammalian cells.


Subject(s)
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide/analogs & derivatives , 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide/metabolism , DNA Adducts , DNA-Directed DNA Polymerase/chemistry , DNA-Directed DNA Polymerase/metabolism , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/metabolism , Purines/chemistry , Binding Sites , Dose-Response Relationship, Drug , Humans , Kinetics , Magnetic Resonance Spectroscopy , Models, Chemical , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...